Trial Court Dismisses Securities Fraud Complaint for Insufficient "Evidence" The Case of Nektar Therapeutics, Inc.
By EsqSocial Corporation 01/03/21
Introduction - Pleading requirements in federal courts, particularly in securities class action cases, have become increasingly difficult, if not impossible, to satisfy....
By: Arnall Golden Gregory LLP